188 related articles for article (PubMed ID: 17342030)
1. The molecular basis of diabetic microangiopathy.
Mokini Z; Chiarelli F
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):138-52. PubMed ID: 17342030
[TBL] [Abstract][Full Text] [Related]
2. Diabetic microvascular complications and growth factors.
Pfeiffer A; Schatz H
Exp Clin Endocrinol Diabetes; 1995; 103(1):7-14. PubMed ID: 7621107
[TBL] [Abstract][Full Text] [Related]
3. The microvasculature in type 1 diabetes.
Shore AC
Semin Vasc Med; 2002 Feb; 2(1):9-20. PubMed ID: 16222592
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.
Madonna R; De Caterina R
Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786
[TBL] [Abstract][Full Text] [Related]
5. Diabetic microangiopathy: pathology and current understanding of its pathogenesis.
Yagihashi S; Wada R; Yamagishi S
Verh Dtsch Ges Pathol; 2002; 86():91-100. PubMed ID: 12647356
[TBL] [Abstract][Full Text] [Related]
6. [Molecular aspects of chronic hyperglycemia-induced tissue damage].
Díaz-Flores M; Baiza-Gutman LA; Ibáñez-Hernández MA; Pascoe-Lira D; Guzmán-Greenfel AM; Kumate-Rodríguez J
Gac Med Mex; 2004; 140(4):437-47. PubMed ID: 15456154
[TBL] [Abstract][Full Text] [Related]
7. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
Camera A; Hopps E; Caimi G
Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
[TBL] [Abstract][Full Text] [Related]
8. Microvascular permeability in diabetes and insulin resistance.
Yuan SY; Breslin JW; Perrin R; Gaudreault N; Guo M; Kargozaran H; Wu MH
Microcirculation; 2007; 14(4-5):363-73. PubMed ID: 17613808
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycaemia, microangiopathy, diabetes and dementia risk.
Bourdel-Marchasson I; Mouries A; Helmer C
Diabetes Metab; 2010 Oct; 36 Suppl 3():S112-8. PubMed ID: 21211732
[TBL] [Abstract][Full Text] [Related]
11. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy.
Adaikalakoteswari A; Rema M; Mohan V; Balasubramanyam M
Int J Biochem Cell Biol; 2007; 39(9):1673-84. PubMed ID: 17540609
[TBL] [Abstract][Full Text] [Related]
12. [Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2].
Knapik-Kordecka M; Piwowar A; Warwas M
Wiad Lek; 2007; 60(7-8):329-34. PubMed ID: 18175551
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic neuropathy].
Chudzik W; Kaczorowska B; Przybyła M; Chudzik B; Gałka M
Pol Merkur Lekarski; 2007 Jan; 22(127):66-9. PubMed ID: 17477095
[TBL] [Abstract][Full Text] [Related]
14. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes.
Son SM
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S65-70. PubMed ID: 17467110
[TBL] [Abstract][Full Text] [Related]
15. [Perspective for the treatment of diabetic neuropathy: translation from molecular studies to bedside].
Yagihashi S; Yamagishi S; Wada R
Rinsho Shinkeigaku; 2005 Nov; 45(11):966-8. PubMed ID: 16447775
[TBL] [Abstract][Full Text] [Related]
16. The cellular and molecular mechanisms of diabetic complications.
King GL; Brownlee M
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities.
Capellini VK; Celotto AC; Baldo CF; Olivon VC; Viaro F; Rodrigues AJ; Evora PR
Curr Vasc Pharmacol; 2010 Jul; 8(4):526-44. PubMed ID: 19485895
[TBL] [Abstract][Full Text] [Related]
18. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches.
Madonna R; Balistreri CR; Geng YJ; De Caterina R
Vascul Pharmacol; 2017 Mar; 90():1-7. PubMed ID: 28137665
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycaemia, microvascular disease and 'true diabetes".
Keen H; Jarrett RJ
Diabete Metab; 1979 Jun; 5(2):89-91. PubMed ID: 478087
[No Abstract] [Full Text] [Related]
20. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
Paul S; Ali A; Katare R
J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
